Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha

Saved in:
Bibliographic Details
Published inRevista clínica espanõla Vol. 211; no. 8; p. 436
Main Authors Montero-Tinnirello, J, de la Fuente-Aguado, J, Rodríguez-Pecci, M S, Fernández-Fernández, F J
Format Journal Article
LanguageSpanish
Published Spain 01.09.2011
Subjects
Adult
Aged
Antiviral Agents - adverse effects
Antiviral Agents - therapeutic use
Female
Hepatitis C, Chronic - drug therapy
Humans
Interferon-alpha - adverse effects
Interferon-alpha - therapeutic use
Male
Middle Aged
Polyethylene Glycols - adverse effects
Polyethylene Glycols - therapeutic use
Recombinant Proteins - adverse effects
Recombinant Proteins - therapeutic use
Thyroid Diseases - chemically induced
Young Adult
Online AccessGet more information

Cover

More Information
ISSN:1578-1860
DOI:10.1016/j.rce.2011.01.021